Erectile Dysfunction Symptoms in Polydrug Dependents Seeking Treatment

Página do item simplificado
dc.citation.issue12
dc.citation.volume52
dc.contributor.authorClemente, Jales [UNIFESP]
dc.contributor.authorDiehl, Alessandra [UNIFESP]
dc.contributor.authorSantana, Paulo Roberto Oliveira Henrique
dc.contributor.authorSilva, Cláudio Jerônimo da [UNIFESP]
dc.contributor.authorPillon, Sandra Cristina
dc.contributor.authorMari, Jair de Jesus [UNIFESP]
dc.coveragePhiladelphia
dc.date.accessioned2020-07-17T14:03:32Z
dc.date.available2020-07-17T14:03:32Z
dc.date.issued2017
dc.description.abstractObjective: To assess erectile dysfunction (ED) symptom prevalence, sexual behavior conditions, and risk factors associated to ED in a male polydrug dependent sample. Methods: A cross-sectional design study was conducted with 102 substance-dependent male polydrug users who sought outpatient treatment in Sao Paulo, Brazil. Sociodemographic data, drug of choice, chronic disease questions, sexually transmitted infections, International Index of Erectile Function (IIEF) scale, Sexual Addiction Screening Test (SAST), and WHOQOL-Bref instrument were used. Results: The erectile dysfunction prevalence was 32.3% and it was related to the marital status (single) (p < 0.001), occupational status (fully unemployed) (p < 0.001), presenting a chronic disease (p = 0.027), and with types of sexual partnerships (occasional partner) (p < 0.001). Alcohol (73.5%), tobacco (79.4%), cannabis (83.3%), and cocaine (snorted 78.4% and smoked 42.2%) were the drugs of choice. The ED risk decreased when marital status was married (odds ratio = 3.2 CI95% 1.411-7.518) and with chronic disease (odds ratio 0.06 CI95% 0.00-0.97), while having occasional sexual partners increased 14 times ED risk (OR 14.0 CI95% 1.62-122.18). There were no significant associations between quality of life, DOC and ED. Conclusion: Approximately one third of the substance dependents in this sample presented ED. There is a need to integrate psychiatric and clinical care in substance treatment services, and to improve the provision of sexual health care and support available for this population.en
dc.description.affiliationFed Univ Sao Paulo UNIFESP, Dept Psychiat, Sao Paulo, Brazil
dc.description.affiliationAmer Bairral Inst, Sao Paulo, Brazil
dc.description.affiliationUniv Sao Paulo, Psychiat Nursing & Human Sci Dept, Ribeirao Preto Coll Nursing, Ribeirao Preto, Brazil
dc.description.affiliationUnifespFed Univ Sao Paulo UNIFESP, Dept Psychiat, Sao Paulo, Brazil
dc.description.sourceWeb of Science
dc.format.extent1565-1574
dc.identifierhttps://dx.doi.org/10.1080/10826084.2017.1290114
dc.identifier.citationSubstance Use & Misuse. Philadelphia, v. 52, n. 12, p. 1565-1574, 2017.
dc.identifier.doi10.1080/10826084.2017.1290114
dc.identifier.issn1082-6084
dc.identifier.urihttps://repositorio.unifesp.br/handle/11600/55477
dc.identifier.wosWOS:000409301400005
dc.language.isoeng
dc.publisherTaylor & Francis Inc
dc.relation.ispartofSubstance Use & Misuse
dc.rightsinfo:eu-repo/semantics/restrictedAccess
dc.subjectErectile dysfunctionen
dc.subjectSubstance-related disordersen
dc.subjectMenen
dc.subjectTreatmenten
dc.subjectQuality of lifeen
dc.titleErectile Dysfunction Symptoms in Polydrug Dependents Seeking Treatmenten
dc.typeinfo:eu-repo/semantics/article
Arquivos
Coleções
EPM - Artigos